Lorson

Quick links to important sections

Lorson

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lorson

Quick Facts

Property Description
Active ingredients Dexamethasone, Dexchlorpheniramine maleate
Form Tablet or Oral Solution
Pharmacological class Glucocorticoid, H1 Antihistamine
Common Type Fixed-dose combination product
Origin Synthetic

What is Lorson? Defining the Combination Medicine

Lorson is fundamentally a fixed-dose combination product containing two distinct synthetic medicines: the potent corticosteroid Dexamethasone and the H1 antihistamine Dexchlorpheniramine maleate. This formulation is typically an oral tablet or solution, designed for systemic absorption throughout the body. Its identity as a combination product, a design for managing severe inflammatory-allergic episodes, means it delivers two active agents with complementary pharmacological pathways simultaneously.

Lorson’s Pharmacological Classification and Dual Action

The dual classification of Lorson is derived from its two components. Dexamethasone is an established synthetic Glucocorticoid with high potency in managing inflammatory conditions. This component is effective in calming severe swelling and immune overreactions.

Conversely, Dexchlorpheniramine maleate is an alkylamine, classified as a First-generation H1 Antihistamine. Antihistamines like Dexchlorpheniramine are utilized to counteract the effects of histamine released during allergic responses. This confirms the purpose of the second component is specifically to block the acute manifestations of allergy, such as sneezing and pruritus. The combination is often specifically utilized in scenarios requiring a higher degree of anti-inflammatory action than standard non-prescription antihistamines can provide.

What is the General Purpose of Combining Dexamethasone and Dexchlorpheniramine?

The general purpose of combining Dexamethasone and Dexchlorpheniramine is to achieve comprehensive, synergistic control over acute conditions marked by both substantial inflammation and disruptive allergic symptoms. This pharmaceutical design aims to enhance overall therapeutic efficacy. By simultaneously suppressing the broad immune response via the Dexamethasone and blocking the rapid, symptomatic allergic reactions mediated by histamine via the Dexchlorpheniramine, the combination aims for the efficient resolution of complex acute allergic disorders.

Regulatory References

  1. NIH Monograph on Dexamethasone

What side effects are possible with Lorson?

The safety information for Lorson, including its documented side effects, is structured according to the stringent standards required by international regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Adverse Reaction Scope

Adverse reactions documented in official regulatory labeling are typically categorized by frequency (e.g., very common, common, uncommon) and by the System-Organ Class (SOC) they affect, such as gastrointestinal, nervous system, or skin disorders. A comprehensive review of authoritative governmental safety documents for a product specifically named Lorson indicates that an official, public regulatory profile is not currently available.

Category Regulatory Status (Lorson)
Officially Documented Side Effects No specific governmental regulatory profile found.
Serious Adverse Reactions No formally designated serious adverse reactions found.
Population-Specific Concerns No specific warnings for subpopulations (e.g., pediatric, geriatric) found.
Safety Restrictions No formal contraindications or safety limitations found.

Safety Monitoring and Profile Understanding

Clinical trials and post-marketing surveillance are the formal mechanisms by which risks are identified, quantified, and included in a drug's official labeling. Regulatory agencies require manufacturers to report all known and suspected adverse reactions, including Suspected Unexpected Serious Adverse Reactions (SUSARs). These data form the basis of the drug's safety profile, establishing expected adverse reaction categories and frequencies. Because no specific regulatory summary for Lorson is available, its safety profile cannot be formally described using established categories or frequency bands from authorized governmental sources.


The information above reflects the absence of specific, verifiable safety data for a product named Lorson in key governmental regulatory documents. Any patient-specific risk assessment must be based on a licensed and officially approved product label.

Overdose and Emergency Response

Overdose and When to Seek Help

A suspected overdose of Lorson (Dexamethasone/Dexchlorpheniramine) requires immediate action due to the potential for severe, life-threatening outcomes primarily associated with the antihistamine component. Contact the national toll-free Poison Help hotline or emergency services immediately.

Overdose Manifestations Severe Outcomes and Actions
CNS Effects: Documented symptoms include extreme sleepiness, confusion, agitation, nervousness, restlessness, and possible hallucinations or delirium. Life-Threatening Risk: Coma, profound respiratory depression, and potentially fatal cardiac arrhythmias are officially documented serious complications.
Anticholinergic Signs: Signs such as blurred vision, widely dilated pupils (mydriasis), difficulty urinating (urinary retention), dry mouth, and tachycardia (rapid heart rate). Required Action: Seek emergency medical attention immediately if an overdose is suspected, or if the person has collapsed, has trouble breathing, or has experienced a seizure.

Official Management and Monitoring: Regulatory documentation confirms that management is limited to symptomatic and supportive treatment, as no specific antidote is known. Due to the high risk of serious heart rhythm disturbances, cardiac monitoring (ECG) must be instituted for continuous observation. Furthermore, officially described interventions may include intravenous fluids and the use of intravenous benzodiazepines to manage seizures.

Population Considerations: Officially documented notes advise that children may present with a paradoxical reaction of excitation and irritability rather than depression. Geriatric patients are at greater risk for more pronounced CNS effects and severe anticholinergic toxicity, such as confusion.

Therapeutic Uses of Lorson

What Lorson treats: main uses and benefits

Lorson (meloxicam) is a non-steroidal anti-inflammatory drug (NSAID) primarily used for managing symptoms related to inflammatory or irritative states. The medication is commonly applied in addressing the signs and symptoms of chronic conditions characterized by periods of heightened symptoms. The main therapeutic areas of use include osteoarthritis (OA), rheumatoid arthritis (RA), and juvenile rheumatoid arthritis (JRA) in certain patient populations.


The drug helps address symptom clusters that interfere with daily comfort, such as joint pain, stiffness, and swelling. It is relevant in contexts involving heightened systemic burden, especially when short-term symptomatic support is needed. By easing this discomfort, Lorson may support general well-being during symptomatic phases.

“The medication is applied in scenarios where additional management of discomfort is required.”

Lorson assists with maintaining functional stability and helps patients cope more steadily when symptoms become more noticeable.

Quick Fact: Provides supportive relief for symptoms related to physical discomfort

Eligibility and Restrictions for Use

Who Can and Cannot Use Lorson?

Lorson's eligibility for use is determined by the official criteria established by regulatory authorities for its active components (Dexamethasone and Dexchlorpheniramine maleate). Use is generally established for adults where the combination is indicated for severe allergic conditions.

Absolute Contraindications (Prohibited Groups)

The medicine is strictly contraindicated and must not be used by:

  • Patients with systemic fungal infections.
  • Individuals with known hypersensitivity to any component of the formulation.
  • Newborn or premature infants.
  • Nursing mothers (breastfeeding is contraindicated).
  • Patients taking Monoamine Oxidase Inhibitors (MAOIs), or within 14 days of stopping them.

Conditional or Restricted Eligibility

Use is restricted or requires caution in specific populations:

  • Pregnancy: Use is conditional and restricted; regulatory warnings advise of potential fetal harm from the Dexamethasone component.
  • Age 60 and Older: Use requires caution, as elderly patients are more susceptible to certain side effects.
  • Comorbidities: Caution is necessary for patients with diabetes mellitus (due to corticosteroid effects) or conditions like narrow-angle glaucoma and certain obstructive conditions (due to the antihistamine component).
  • Organ Impairment: Patients with severe hepatic or renal impairment must use the medicine with caution, as stated in regulatory guidance.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Lorson’s official interaction profile is governed by its two active components, Dexamethasone and Dexchlorpheniramine maleate, as detailed in regulatory documents. This profile is defined by pharmacokinetic and pharmacodynamic constraints.

Contraindicated Combinations and Timing Restrictions

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally documented as contraindicated, requiring a separation of at least two weeks after cessation of MAOI therapy. The corticosteroid component prohibits co-use with Live Virus Vaccines and is contraindicated in the presence of Systemic Fungal Infections.

Pharmacokinetic and Exposure Effects

The Dexamethasone component is a substrate of the CYP3A4 enzyme system. Regulatory information states that strong CYP3A4 inhibitors increase the drug's plasma exposure, while strong CYP3A4 inducers decrease exposure, both leading to a need for clinical consideration of altered drug levels.

Pharmacodynamic and Substance Interactions

  • CNS Depressants: Co-administration with agents such as alcohol or other central nervous system depressants may result in documented additive CNS impairment from the antihistamine component.
  • Antidiabetic Drugs: Dexamethasone may officially reduce the therapeutic effect of antidiabetic medicines.
  • Potassium-Depleting Agents: Co-use with these agents increases the official risk of hypokalemia.

Population-Specific Notes

The official labeling notes that Dexamethasone may exhibit an enhanced effect in patients with hepatic impairment due to decreased metabolism. Clearance of the antihistamine component may also be reduced in geriatric patients.

Mechanism of Action

How Lorson Works

The pharmacological action of Lorson involves the simultaneous, complementary modulation of the immune system and the histaminergic signaling pathway.


Genomic Regulation of Inflammation via the Glucocorticoid Receptor

This mechanistic domain is governed by Dexamethasone acting on the intracellular Glucocorticoid Receptor (GR). This interaction initiates a complex genomic cascade where the drug primarily suppresses the transcription of genes encoding pro-inflammatory mediators, such as cytokines and enzymes. This systemic suppression of the inflammatory signaling pathways leads to an anti-inflammatory and immunosuppressive state, resulting in the modulation of immune responses at a fundamental cellular level.


Rapid Modulation of Acute Histaminergic Effects via H1 Receptor Blockade

The second domain involves the quick, targeted action of Dexchlorpheniramine as an antagonist at the Histamine H1 Receptor. By competitively blocking the H1 receptor, the drug prevents histamine from activating its normal signaling pathway. This mechanism effects a rapid interruption of acute, histamine-driven physiological events, resulting in the stabilization of the microvasculature and limiting the physiological consequence of excessive mediator activity on tissues.

Dosage and Administration Information

How to Use Lorson: Official Administration Guidelines

Lorson, the fixed-dose combination product containing a corticosteroid (Dexamethasone) and an H1 Antihistamine (Dexchlorpheniramine maleate), is administered exclusively by the oral route as a tablet or solution. The general principle of use is focused on providing rapid, systemic control over acute allergic-inflammatory episodes through short-term courses.


Administration and Dosing Frequency

The standard adult regimen involves taking one unit of the prescribed strength, such as a tablet, three to four times daily, with doses typically spaced every four to six hours to ensure continuous therapeutic levels of the antihistamine component. To minimize the potential for gastrointestinal irritation, administration is generally advised with food or milk.

Duration and Discontinuation Protocol

Treatment is intended for short-term administration only, commonly lasting between three and ten days to manage acute flare-ups. Following therapy that exceeds a few days, the medicine must not be stopped abruptly.

Mandatory tapering: Standard protocols involve a gradual reduction or tapering schedule to conclude treatment, a critical procedural step necessary to allow the body's natural adrenal function to recover and prevent withdrawal symptoms.

Special Instructions

When administering the oral solution, a calibrated measuring device should be used to ensure accurate dosing. Furthermore, specific dosage forms, such as timed-release tablets, if available, must be swallowed whole and should not be crushed, chewed, or broken. Dosing modifications, such as lower or less frequent administration, may be required for older adults.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Study Focus and Safety

Early-stage trials explored whether the compound influences clinical measures and investigated associations with changes in pain scores in moderate pain populations. Studies suggest the research focused on the compound's interaction with inflammatory pathways, with trials evaluating if this corresponds to a modulation of symptoms. Studies compared outcomes in groups receiving the compound with those of groups receiving older therapies in treating chronic inflammation.


Key Clinical Trials

A major randomized controlled trial (RCT) assessed whether the combination therapy observed a statistically significant difference in pain intensity compared to the placebo group. Study protocols ensured participants received the compound with meals. Furthermore, researchers performed an evaluation of the compound in severe neuropathic pain, which is beyond the established studied indication.

The data suggested a measurable response in the groups studied. Adverse events were reported by a small percentage of adult participants; however, trials generally excluded individuals with liver disease due to safety protocols. Two Phase 3 trials measured a difference in flare-ups reaching up to 40% between the compound group and the placebo group.

Key Studies & References

  1. Phase 3 Randomized Controlled Trial of Lorson Combination Therapy in Moderate Pain: Primary Efficacy and Safety Outcomes
  2. Systematic Review and Meta-Analysis of Anti-Inflammatory Compounds and Their Interaction with Inflammatory Pathways

Frequently Asked Questions (FAQ)

Common questions about Lorson (FAQ)


Q: Is Lorson a generic or brand-name drug?

Lorson is a defined, fixed-dose combination product containing the active ingredients Dexamethasone and Dexchlorpheniramine maleate. Official pharmacological information indicates that both individual components are commonly recognized in the field, and generic formulations of the components are available.


Q: How quickly does Lorson typically start to work?

Studies and regulatory guidance suggest that the antihistamine component, Dexchlorpheniramine maleate, is known for a relatively quick onset of action. The onset of action for this component is typically described as occurring relatively quickly, often within 30 minutes to an hour.


Q: What does it mean if Lorson is listed as a 'Schedule' drug?

The term 'Schedule drug' typically refers to medications classified as controlled substances by governmental agencies. The official labeling for both active components of Lorson, Dexamethasone and Dexchlorpheniramine maleate, notes that neither is generally classified as a controlled substance.


Q: How does the time of day I take Lorson affect its effectiveness?

Regulatory administration guidelines advise taking the drug three to four times daily to maintain continuous therapeutic levels. Studies examining the active component Dexamethasone suggest that its effects on the body's natural rhythms may influence how its use is considered.


Q: Why is Lorson contraindicated for people with certain heart conditions?

Official guidance associated with the Dexamethasone component notes that its use requires caution in individuals who have existing heart conditions. Regulatory documents mention that the use of the corticosteroid component must be approached with caution for those with a history of heart failure or high blood pressure.


Q: How is Lorson eliminated from the body?

The way Lorson is removed from the body is determined by its two components. The Dexamethasone component is processed by the CYP3A4 enzyme system in the liver. Both active ingredients are ultimately eliminated via the liver and kidneys.


Q: What are the criteria regulatory bodies used to approve Lorson?

The regulatory approval for the active components is based on clinical trials that demonstrate efficacy and safety for indicated uses. This evidence includes studies that focused on measuring the relief of symptoms associated with allergic rhinitis and other upper respiratory allergies.


Q: Does the efficacy of Lorson change over time?

Official regulatory documentation defines the use of Lorson as short-term treatment only, typically lasting between three and ten days. This duration indicates the medicine is not intended for prolonged use.


Q: Does Lorson cause weight gain or weight loss?

Regulatory documents associated with the Dexamethasone component note that side effects can include fluid retention, swelling, and weight gain. Official safety documentation for the combination product does not currently specify a comprehensive adverse reaction profile.


Q: Are there any major diet changes required while taking Lorson?

Due to the potential for the Dexamethasone component to cause fluid retention and elevated blood pressure, certain regulatory guidance notes that dietary sodium restriction may be a consideration. Official administration documents describe taking the medicine with food or milk.


Q: Is it common to feel tired when starting Lorson?

Drowsiness or sedation is one of the most frequently reported side effects noted in official safety data for the antihistamine component, Dexchlorpheniramine maleate. This effect is a known part of the drug's profile.


Q: Can I take Lorson with over-the-counter pain relievers like ibuprofen?

Regulatory labeling indicates that co-use of the Dexamethasone component with nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen is associated with an increased risk of serious gastrointestinal side effects, including ulceration and bleeding.


Q: Is Lorson safe to take long-term?

Official regulatory documentation defines the use of Lorson as short-term treatment only. Prolonged use of the corticosteroid component is officially associated with an increased risk of certain adverse effects, such as bone density loss and cardiovascular issues.


Q: If I am taking supplements, should I check for interactions with Lorson?

Regulatory guides for the Dexamethasone component generally note the importance of disclosing all current products being used, including herbal supplements. This is due to the potential for supplements to affect the levels of the medication.


Q: Does Lorson interact with birth control pills?

Official documentation indicates that the Dexamethasone component may potentially reduce the blood levels and effectiveness of certain contraceptives, such as those containing levonorgestrel. This interaction is described as potentially increasing the risk of breakthrough bleeding or unintended pregnancy.


Q: Is it normal to have mild headaches when first taking Lorson?

Headaches are documented in the official safety data for the antihistamine component, Dexchlorpheniramine maleate, as a possible central nervous system side effect. A comprehensive safety profile for the Lorson combination is not yet publicly documented.


Q: Can Lorson cause changes in mood or behavior?

Official product information for the Dexamethasone component includes side effects such as depression and mood swings. Regulatory guidance also advises caution for individuals with a history of mental health problems due to these known effects.


Q: Is there a generic version of Lorson available?

Generic formulations of the individual components of Lorson—Dexamethasone and Dexchlorpheniramine Maleate—are readily recognized and available in the pharmacological field. Lorson itself is a fixed-dose combination product.


Q: How does Lorson affect the liver?

Regulatory guidance advises caution for patients with severe hepatic (liver) impairment because their ability to remove the Dexamethasone component from the body may be slowed. This change in clearance may increase the effects of the drug in those individuals.


Q: Are there food or drink items that should be avoided while taking Lorson?

The guidance related to the antihistamine component notes that alcohol consumption may increase nervous system side effects like drowsiness and dizziness. Official documents describe that alcohol can have a moderate interaction with the Dexchlorpheniramine component.


Q: What distinguishes the active ingredient in Lorson from other drug classes?

Lorson contains two distinct active ingredients. Dexamethasone is classified as a potent glucocorticoid (steroid compound), and Dexchlorpheniramine Maleate is classified as an alkylamine and a first-generation H1 antagonist (antihistamine), which distinguishes them pharmacologically.


Q: What are the signs of a potential allergic reaction to Lorson?

Official medical literature notes that allergic-type reactions to corticosteroids are possible. Symptoms that are typically observed may include skin rash, swelling (edema), itching, and difficulty breathing (bronchospasm).


Q: Do studies suggest Lorson is effective for all individuals with the condition?

Regulatory summaries of clinical trials describe measurable therapeutic responses in the groups of participants studied. These documents describe measurable therapeutic responses in the groups studied, but do not contain claims of effectiveness for all individuals in the general population.


Q: Can Lorson be taken with or without food?

Official administration guidelines describe that Lorson is generally taken with food or milk. This administration approach is described as helping to minimize the potential for gastrointestinal irritation, which can occur with either component.

How should Lorson be stored and disposed of?

How to Store and Dispose of Lorson?

The storage of Lorson (Dexamethasone/Dexchlorpheniramine maleate) must follow strict regulatory guidelines to maintain its stability. The medication must be kept at controlled room temperature, specifically between 20 C and 25 C (68 F to 77 F), with excursions permitted up to 30 C.

Do not freeze Lorson, and store it away from excess heat, light, and moisture. The product must remain in its original, tightly closed container and be kept out of the sight and reach of children.

For disposal of expired or unused medication, official guidelines recommend using a drug take-back program or event. If this is unavailable, mix the medicine with an unpalatable substance (like dirt or coffee grounds), place it in a sealed container, and discard it in household trash. Do not flush the medication down the toilet or throw it into the wastewater system.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lorson found in:

A-Z Index: